You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

October 17, 2019

Alan Adcock Quoted by Asian Legal Business on Cannabis Liberalization in Thailand

Asian Legal Business

Alan Adcock, partner and deputy director of Tilleke & Gibbins’ intellectual property practice, shared his expertise on Thailand’s ongoing cannabis liberalization efforts in the October 2019 issue of Asian Legal Business.

The article is built around Alan’s insights, gleaned from his deep and up-to-date knowledge of the burgeoning cannabis industry and regulatory regime in Thailand. In the article he discusses the significance of the law legalizing cannabis for medical use and research, the opportunities it presents for businesses in the cannabis industry, and the current and expected legal environment surrounding cannabis-related activities. In explaining how entrepreneurs and cannabis companies can get involved in Thailand’s cannabis industry, he also notes that liberalization of cannabis for medical use is expected to take hold elsewhere in Asia, and one way companies can act on this is by establishing operations in Thailand as a base for further expansion. Finally, Alan outlines that legal professionals are also playing an important role by staying on top of developments for their clients and advising on pathways forward in this tightly regulated, newly opening market.

To read the full issue, please visit the Asian Legal Business  website. For questions about the cannabis industry and regulatory environment in Thailand, please contact Tilleke & Gibbins at [email protected].

RELATED INSIGHTS​ 

October 12, 2012
On November 22, 2012, the Euromoney Legal Media Group will hold its second annual Asia Women in Business Law Awards at the Renaissance Harbour View Hotel in Hong Kong. Again this year, Tilleke & Gibbins stands amongst a leading group of law firms that will be recognized for their commitment to the advancement of women. The firms will be judged on a range of factors, predominately initiatives for gender diversity, innovation, mentoring, talent management, and female leadership within each firm.
September 5, 2012
Starting October 1, 2012, overseas pharmaceutical manufacturers that have never before been recorded in the Drug Product Registry of Thailand will need to be accredited by the Thai Food and Drug Administration (FDA) before marketing authorization can be obtained. Otherwise, the FDA will not allow the business operator to submit an Application for Importation of Drug Product Sample, which is a required document for drug product registration.
September 4, 2012
On September 21, 2012, Tilleke & Gibbins, together with the National Innovation Agency, will host a Thai-language seminar on “Medical Devices: Opportunities & Regulations.” The seminar with consist of three presentations, one of which will be conducted by Rarana Phanudulkitti, a consultant at Tilleke & Gibbins. With her expertise in regulatory affairs, Rarana will deal specifically with registering medical devices in Thailand, with an emphasis on best practices for companies in ensuring a smooth registration process.